Literature DB >> 10419479

Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II.

S Olland1, J C Wang.   

Abstract

Catalysis of ATP hydrolysis by two NH(2)-terminal fragments of yeast DNA topoisomerase II was studied in the absence and presence of DNA, and in the absence and presence of inhibitor ICRF-193. The results indicate that purified Top2-(1-409), a fragment containing the NH(2)-terminal 409 amino acids of the yeast enzyme, is predominantly monomeric, with a low level of ATPase owing to weak association of two monomers to form a catalytically active dimer. The ATPase activity of Top2-(1-409) is independent of DNA in a buffer containing 100 mM NaCl, in which intact yeast DNA topoisomerase II exhibits robust DNA-dependent ATPase and DNA transport activities. Purified Top2-(1-660), a fragment containing the NH(2)-terminal 660 amino acid of the yeast enzyme, appears to be dimeric in the absence or presence of DNA, and the ATPase activity of the protein is significantly stimulated by DNA. These results are consistent with a model in which binding of an intact DNA topoisomerase II to DNA places the various subfragments of the enzyme in a way that makes the intramolecular dimerization of the ATPase domains more favorable. We believe that this alignment of subfragments is mainly achieved through the binding of the enzyme to the DNA segment within which the enzyme makes transient breaks. The ATPase activity of Top2-(1-409) is inhibited by ICRF-193, suggesting that the bisdioxopiperazine class of DNA topoisomerase II inhibitors directly interacts with the paired ATPase domains of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10419479     DOI: 10.1074/jbc.274.31.21688

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  14 in total

1.  Single-molecule Förster resonance energy transfer (FRET) analysis discloses the dynamics of the DNA-topoisomerase II (Top2) interaction in the presence of TOP2-targeting agents.

Authors:  Wan-Chen Huang; Chun-Ying Lee; Tao-Shih Hsieh
Journal:  J Biol Chem       Date:  2017-06-19       Impact factor: 5.157

2.  Molecular cloning of apicoplast-targeted Plasmodium falciparum DNA gyrase genes: unique intrinsic ATPase activity and ATP-independent dimerization of PfGyrB subunit.

Authors:  Mohd Ashraf Dar; Atul Sharma; Neelima Mondal; Suman Kumar Dhar
Journal:  Eukaryot Cell       Date:  2007-01-12

3.  Dynamics of strand passage catalyzed by topoisomerase II.

Authors:  Ping Xie
Journal:  Eur Biophys J       Date:  2010-02-03       Impact factor: 1.733

Review 4.  Topoisomerases as anticancer targets.

Authors:  Justine L Delgado; Chao-Ming Hsieh; Nei-Li Chan; Hiroshi Hiasa
Journal:  Biochem J       Date:  2018-01-23       Impact factor: 3.857

5.  Characterization of the ATPase activity of topoisomerase II from Leishmania donovani and identification of residues conferring resistance to etoposide.

Authors:  Tanushri Sengupta; Mandira Mukherjee; Aditi Das; Chhabinath Mandal; Rakhee Das; Tanmoy Mukherjee; Hemanta K Majumder
Journal:  Biochem J       Date:  2005-09-01       Impact factor: 3.857

6.  Revised genetic requirements for the decatenation G2 checkpoint: the role of ATM.

Authors:  Jacquelyn J Bower; Yingchun Zhou; Tong Zhou; Dennis A Simpson; Sonnet J Arlander; Richard S Paules; Marila Cordeiro-Stone; William K Kaufmann
Journal:  Cell Cycle       Date:  2010-04-15       Impact factor: 4.534

7.  A unique 45-amino-acid region in the toprim domain of Plasmodium falciparum gyrase B is essential for its activity.

Authors:  Ashraf Dar; Dhaneswar Prusty; Neelima Mondal; Suman K Dhar
Journal:  Eukaryot Cell       Date:  2009-08-21

8.  Structure of the topoisomerase II ATPase region and its mechanism of inhibition by the chemotherapeutic agent ICRF-187.

Authors:  Scott Classen; Stephane Olland; James M Berger
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-08       Impact factor: 11.205

9.  Characterisation of the DNA-dependent ATPase activity of human DNA topoisomerase IIbeta: mutation of Ser165 in the ATPase domain reduces the ATPase activity and abolishes the in vivo complementation ability.

Authors:  Katherine L West; Rosalind M Turnbull; Elaine Willmore; Jeremy H Lakey; Caroline A Austin
Journal:  Nucleic Acids Res       Date:  2002-12-15       Impact factor: 16.971

10.  The pentapeptide-repeat protein, MfpA, interacts with mycobacterial DNA gyrase as a DNA T-segment mimic.

Authors:  Lipeng Feng; Julia E A Mundy; Clare E M Stevenson; Lesley A Mitchenall; David M Lawson; Kaixia Mi; Anthony Maxwell
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-16       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.